---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-042744"
form_type: "8-K"
ticker: "TRVI"
cik: "0001563880"
company_name: "Trevi Therapeutics, Inc."
filed_at: "2021-08-09T23:59:59+00:00"
generated_at: "2026-06-29T18:34:46.021741+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Trevi Therapeutics hires Lisa Delfini as CFO with $330K base salary and 100,000-share option grant

## Summary
- Lisa Delfini appointed CFO and principal financial officer, effective August 9, 2021.
- Base salary of $330,000 and annual incentive bonus up to 35% of base.
- Granted option to purchase 100,000 shares vesting over 4 years (25% on first anniversary, then monthly).
- Eligible for separation benefits under Company plan, with modified terms for termination before Aug 9, 2022.

## SEC filing metadata
- accession: 0001564590-21-042744
- form_type: 8-K
- ticker: TRVI
- cik: 0001563880
- company_name: Trevi Therapeutics, Inc.
- filed_at: 2021-08-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563880/000156459021042744/0001564590-21-042744-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563880/000156459021042744/trvi-8k_20210809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-042744
- JSON: https://secwatch.observer/filing/0001564590-21-042744.json
- Plain text: https://secwatch.observer/filing/0001564590-21-042744.txt

## Key facts
- Executive change
  Lisa Delfini was appointed as Chief Financial Officer and principal financial officer at Trevi Therapeutics, Inc..
  - Action: hired
  - Role: Chief Financial Officer and principal financial officer
  source text: On August 9, 2021, Trevi Therapeutics, Inc. (the “Company”) announced the hiring of Lisa Delfini, who will serve as the Company’s Chief Financial Officer and principal financial officer upon her start date of August 9, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563880/000156459021042744/0001564590-21-042744-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.